Virtus LifeSci Biotech Clinical Tri... (BBC)

$24.4486

+0.13 (+0.55%)
Rating:
Recommendation:
-
Symbol BBC
Price $24.4486
Beta 0.000
Volume Avg. 0.00M
Market Cap -
Shares () -
52 Week Range 17.77-40.86
1y Target Est -
DCF Unlevered BBC DCF ->
DCF Levered BBC LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BBC news


None
New York Stock Exchange Arca

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.